These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9201659)

  • 1. After the menopause: tamoxifen and other new prevention maintenance therapies.
    Jordan VC
    J Womens Health; 1997 Jun; 6(3):257-9. PubMed ID: 9201659
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy and nonhormonal control of menopausal symptoms in breast cancer survivors.
    Cobleigh MA
    Cancer Treat Res; 1998; 94():209-30. PubMed ID: 9587690
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamoxifen: from breast cancer therapy to the design of a postmenopausal prevention maintenance therapy.
    Jordan VC; MacGregor JI; Tonetti DA
    Osteoporos Int; 1997; 7 Suppl 1():S52-7. PubMed ID: 9205647
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted anti-estrogens to treat and prevent diseases in women.
    Tonetti DA; Jordan VC
    Mol Med Today; 1996 May; 2(5):218-23. PubMed ID: 8796891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal HRT--a role for tamoxifen?
    Jackson G
    Int J Clin Pract; 1997; 51(5):267. PubMed ID: 9489081
    [No Abstract]   [Full Text] [Related]  

  • 6. Designer estrogens.
    Jordan VC
    Sci Am; 1998 Oct; 279(4):60-7. PubMed ID: 9768522
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
    Jordan VC; Gapstur S; Morrow M
    J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of an ideal hormone replacement therapy for women.
    Tonetti DA; Jordan VC
    Mol Carcinog; 1996 Nov; 17(3):108-11. PubMed ID: 8944069
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-estrogens come of age: a pioneer looks back.
    Nelson NJ
    J Natl Cancer Inst; 1998 May; 90(9):646-7. PubMed ID: 9586657
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress in the prevention of breast cancer: concept to reality.
    Jordan VC
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):269-77. PubMed ID: 11162935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen and menopausal status: risks and benefits.
    Sasco AJ
    Lancet; 1996 Mar; 347(9003):761. PubMed ID: 8602018
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of a new prevention maintenance therapy for postmenopausal women.
    Jordan VC
    Recent Results Cancer Res; 1999; 151():96-109. PubMed ID: 10337721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing breast cancer with tamoxifen.
    Jordan VC
    Hosp Pract (1995); 1998 Sep; 33(9):59-64, 67-8, 71-2; discussion 72, 7. PubMed ID: 9750554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen for the prevention of breast cancer.
    Greenspan EM
    Am J Med; 1996 Jun; 100(6):665. PubMed ID: 8678089
    [No Abstract]   [Full Text] [Related]  

  • 15. Tamoxifen for prevention of breast cancer.
    Med Lett Drugs Ther; 1999 Jan; 41(1043):1-2. PubMed ID: 9924486
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast Cancer Prevention Trial shows major benefit, some risk.
    Smigel K
    J Natl Cancer Inst; 1998 May; 90(9):647-8. PubMed ID: 9586658
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow.
    Jordan VC
    J Natl Cancer Inst; 1998 Jul; 90(13):967-71. PubMed ID: 9665143
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health.
    Goldstein SR
    Int J Fertil Womens Med; 1999; 44(5):221-6. PubMed ID: 10569450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The breast cancer prevention trial (P-1 study). The role of tamoxifen in preventing breast cancer.
    Overmoyer BA
    Cleve Clin J Med; 1999 Jan; 66(1):33-40. PubMed ID: 9926629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen, raloxifene, and the prevention of breast cancer.
    Jordan VC; Morrow M
    Endocr Rev; 1999 Jun; 20(3):253-78. PubMed ID: 10368771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.